During times of natural disasters, many families are forced to evacuate to safety in a hurry with little more than they can carry. With so much to worry about, prescription medicines may be left behind.
Merck KGaA, Darmstadt, Germany, and Pfizer Inc. (NYSE: PFE) today announced that the European Commission (EC) has granted marketing authorization for BAVENCIO® (avelumab) as a monotherapy for the treatment of . . .